Oral Abstracts—Monday, September 24, 2018OA02.06 A Phase II Trial of Poziotinib in EGFR and HER2 exon 20 Mutant Non-Small Cell Lung Cancer (NSCLC)
Under an Elsevier user license
open archive
Cited by (0)
Copyright © 2018 Published by Elsevier Inc.